Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-04

FDA Approved: TETRABENAZINE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for tetrabenazine from Camber Pharmaceuticals, Inc., enabling a generic version to be marketed. This action provides a g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tetrabenazine (tetrabenazine)

Snippet

SUPPL AP for TETRABENAZINE (TETRABENAZINE)